{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:38:55Z","timestamp":1791283135736,"version":"4.1.0"},"reference-count":38,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1876,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1111\/j.1742-1241.2010.02424.x","type":"journal-article","created":{"date-parts":[[2010,7,13]],"date-time":"2010-07-13T03:26:59Z","timestamp":1278991619000},"page":"1252-1259","source":"Crossref","is-referenced-by-count":39,"title":["Cardiovascular risk evaluation and antiretroviral therapy effects in an HIV cohort: implications for clinical management: the CREATE 1 study"],"prefix":"10.1155","volume":"64","author":[{"given":"M.","family":"Aboud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Elgalib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Pomeroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Panayiotakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Skopelitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kulasegaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Dimian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"C Lampe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S.","family":"Wierzbicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. S.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,7,13]]},"reference":[{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJMoa022048","article-title":"Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection","volume":"348","author":"Bozzette","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1097\/00002030-200309260-00008","article-title":"Interventional cardiovascular procedures among HIV-infected individuals on antiretroviral therapy 1995-2000","volume":"17","author":"Braitstein","year":"2003","journal-title":"AIDS"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1086\/317429","article-title":"Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group","volume":"31","author":"Dube","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1","key":"10.1111\/j.1742-1241.2010.02424.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1097\/00126334-200209011-00004","article-title":"Cardiovascular risk associated with HIV therapy","volume":"31","author":"Currier","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1185\/030079905X65529","article-title":"Dyslipidaemia and cardiovascular risk in HIV infection","volume":"21","author":"Kulasegaram","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1742-1241.2006.01267.x","article-title":"Insulin resistance and HIV infection: a review","volume":"61","author":"Aboud","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1185\/030079908X272742","article-title":"HIV lipodystrophy and its metabolic consequences: implications for clinical practice","volume":"24","author":"Wierzbicki","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1161\/CIRCULATIONAHA.107.189624","article-title":"Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy","volume":"118","author":"Currier","year":"2008","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB9|cit9","volume-title":"Putting Prevention First - Vascular Checks: Risk Assessment and Management","author":"Vascular Programme","year":"2008"},{"issue":"1 Pt 2","key":"10.1111\/j.1742-1241.2010.02424.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0002-8703(91)90861-B","article-title":"Cardiovascular disease risk profiles","volume":"121","author":"Anderson","year":"1991","journal-title":"Am Heart J"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/bmj.39609.449676.25","article-title":"Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2","volume":"336","author":"Hippisley-Cox","year":"2008","journal-title":"BMJ"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","article-title":"Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project","volume":"24","author":"Conroy","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1742-1241.2009.02111.x","article-title":"Vascular risk screening: possible or too much, too soon?","volume":"63","author":"Wierzbicki","year":"2009","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10096-004-1177-6","article-title":"Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects","volume":"23","author":"Bergersen","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00002030-200305230-00010","article-title":"Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the DAD study","volume":"17","author":"Friis-Moller","year":"2003","journal-title":"AIDS"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1468-1293.2006.00362.x","article-title":"The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study","volume":"7","author":"Law","year":"2006","journal-title":"HIV Med"},{"issue":"Suppl. 5","key":"10.1111\/j.1742-1241.2010.02424.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1136\/hrt.2005.079988","article-title":"JBS 2: the Joint British Societies\u2019 guidelines for prevention of cardiovascular disease in clinical practice","volume":"91","author":"British Cardiac Society, British Hypertension Society, Diabetes UK","year":"2005","journal-title":"Heart"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB18|cit18","volume-title":"Lipid Modification","author":"National Institute for Health and Clinical Excellence","year":"2008"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB19|cit19","unstructured":"EMIS National User Group University of Nottingham. QResearch Database. QResearch Group 2009 http:\/\/www.qresearch.org"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/j.1742-1241.2008.01828.x","article-title":"Estimated 10-year cardiovascular risk in a British population: results of a national screening project","volume":"62","author":"Neil","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-Moller","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/00365540701230884","article-title":"Is estimated cardiovascular risk higher in HIV-infected patients than in the general population?","volume":"39","author":"De Socio","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jinf.2008.03.007","article-title":"Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: results from the SIMONE study","volume":"57","author":"De Socio","year":"2008","journal-title":"J Infect"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1089\/apc.2006.0165","article-title":"Global cardiovascular risk in patients with HIV infection: concordance and differences in estimates according to three risk equations (Framingham, SCORE, and PROCAM)","volume":"21","author":"Knobel","year":"2007","journal-title":"AIDS Patient Care STDS"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1468-1293.2003.00138.x","article-title":"Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study","volume":"4","author":"Law","year":"2003","journal-title":"HIV Med"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1136\/hrt.2006.092346","article-title":"Primary prevention of cardiovascular disease: a web-based risk score for seven British black and minority ethnic groups","volume":"92","author":"Brindle","year":"2006","journal-title":"Heart"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB27|cit27","first-page":"233","article-title":"The global cardiovascular diseases risk pattern in a peri-urban working-class community in South Africa. The Mamre study","volume":"14","author":"Steyn","year":"2004","journal-title":"Ethn Dis"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/bmj.325.7375.1271","article-title":"Application of Framingham risk estimates to ethnic minorities in United Kingdom and implications for primary prevention of heart disease in general practice: cross sectional population based study","volume":"325","author":"Cappuccio","year":"2002","journal-title":"BMJ"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1210\/jc.2006-2190","article-title":"Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease","volume":"92","author":"Triant","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00043798-200208000-00002","article-title":"Accuracy of cardiovascular risk estimation in patients without diabetes","volume":"9","author":"Reynolds","year":"2002","journal-title":"J Cardiovasc Risk"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1161\/01.CIR.0000124480.32233.8A","article-title":"Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection","volume":"109","author":"Hsue","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.atherosclerosis.2005.06.049","article-title":"Premature atherosclerosis in HIV positive patients and cumulated time of exposure to antiretroviral therapy (SHIVA study)","volume":"185","author":"de Saint","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/COH.0b013e3282fc75fe","article-title":"Guidelines for managing cardiovascular risk: an evolving area","volume":"3","author":"Currier","year":"2008","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1097\/00002030-200109280-00010","article-title":"HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study","volume":"15","author":"Carr","year":"2001","journal-title":"AIDS"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB35|cit35","first-page":"191","article-title":"Switching strategies to improve lipid profile and morphologic changes","volume":"8","author":"Barragan","year":"2006","journal-title":"AIDS Rev"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1468-1293.2007.00541.x","article-title":"Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen","volume":"9","author":"Colafigli","year":"2008","journal-title":"HIV Med"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1517\/17425250903321514","article-title":"Clinical pharmacology, efficacy and safety of atazanavir: a review","volume":"5","author":"Bentue-Ferrer","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1111\/j.1742-1241.2010.02424.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/QAI.0b013e318157131c","article-title":"Rapid and durable antiretroviral effect of the HIV-1 integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study","volume":"46","author":"Markowitz","year":"2007","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2010.02424.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2010.02424.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T01:07:15Z","timestamp":1643332035000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2010.02424.x"}},"subtitle":["CREATE HIV LIPID"],"short-title":[],"issued":{"date-parts":[[2010,7,13]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2010.02424.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7,13]]}}}